Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors
G Giaccone, Y Wang - Cancer treatment reviews, 2011 - Elsevier
The first-generation epidermal growth factor receptor tyrosine kinase inhibitors erlotinib and
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors
G Giaccone, Y Wang - Cancer treatment reviews, 2011 - pubmed.ncbi.nlm.nih.gov
The first-generation epidermal growth factor receptor tyrosine kinase inhibitors erlotinib and
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors
G Giaccone, Y Wang - Cancer Treatment Reviews, 2011 - infona.pl
The first-generation epidermal growth factor receptor tyrosine kinase inhibitors erlotinib and
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
[HTML][HTML] Strategies for Overcoming Resistance to EGFR Family Tyrosine Kinase Inhibitors
G Giaccone, Y Wang - Cancer treatment reviews, 2011 - ncbi.nlm.nih.gov
The first-generation epidermal growth factor receptor tyrosine kinase inhibitors erlotinib and
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
[引用][C] Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors
G Giaccone - Cancer Treat Rev, 2011 - cir.nii.ac.jp
Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors
G Giaccone, Y Wang - Cancer Treatment Reviews, 2011 - cancertreatmentreviews.com
The first-generation epidermal growth factor receptor tyrosine kinase inhibitors erlotinib and
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors.
G Giaccone, Y Wang - Cancer Treatment Reviews, 2011 - europepmc.org
The first-generation epidermal growth factor receptor tyrosine kinase inhibitors erlotinib and
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors
G Giaccone, Y Wang - Cancer Treatment Reviews, 2011 - infona.pl
The first-generation epidermal growth factor receptor tyrosine kinase inhibitors erlotinib and
gefitinib have been incorporated into treatment paradigms for patients with advanced non …
gefitinib have been incorporated into treatment paradigms for patients with advanced non …